Order Article Reprints

Ye J, Qin SS, Hughson AL, Hannon G, Vrooman TG, Lesch ML, Eckl SL, Benoodt L, Mills BN, Lord EM, et al. Blockade of LIF and PD-L1 Enhances Chemotherapy in Preclinical PDAC Models. Cancers. 2025; 17(2):204. https://doi.org/10.3390/cancers17020204

Ye, Jian, Shuyang S. Qin, Angela L. Hughson, Gary Hannon, Tara G. Vrooman, Maggie L. Lesch, Sarah L. Eckl, Lauren Benoodt, Bradley N. Mills, Edith M. Lord, and et al. 2025. "Blockade of LIF and PD-L1 Enhances Chemotherapy in Preclinical PDAC Models" Cancers 17, no. 2: 204. https://doi.org/10.3390/cancers17020204

Ye, J., Qin, S. S., Hughson, A. L., Hannon, G., Vrooman, T. G., Lesch, M. L., Eckl, S. L., Benoodt, L., Mills, B. N., Lord, E. M., Belt, B. A., Linehan, D. C., Luheshi, N., Eyles, J., & Gerber, S. A. (2025). Blockade of LIF and PD-L1 Enhances Chemotherapy in Preclinical PDAC Models. Cancers, 17(2), 204. https://doi.org/10.3390/cancers17020204